Nasal Polyp

A nasal polyp is a benign, pedunculated or sessile, inflammatory or hyperplastic growth arising from the mucous membrane of the nasal cavity or paranasal sinuses. In veterinary medicine, nasal polyps are most commonly reported in cats, where they are often referred to as nasopharyngeal polyps, as they may extend from the middle ear or eustachian tube into the nasopharynx. In dogs, nasal polyps are less common and may arise from the nasal mucosa or paranasal sinuses. These growths are typically non-neoplastic, but they can cause significant clinical signs due to mechanical obstruction, secondary bacterial infection, and inflammation. Nasal polyps are classified based on their location (nasal, nasopharyngeal, or aural) and histologic appearance (inflammatory, fibroepithelial, or glandular). They are distinct from malignant neoplasms such as adenocarcinoma, chondrosarcoma, or lymphoma, which have different biological behavior and prognosis.

The exact etiology of nasal polyps in veterinary patients is not fully understood, but several factors are implicated. Chronic inflammation is considered a primary trigger, often secondary to infectious agents (viral, bacterial, fungal), allergic rhinitis, or foreign body reactions. In cats, chronic upper respiratory infections, particularly with feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV), are believed to contribute to the development of nasopharyngeal polyps. Bacterial infections, including Bordetella bronchiseptica, Mycoplasma spp., and Pasteurella multocida, may also play a role. In dogs, chronic rhinitis due to aspergillosis, foreign bodies, or dental disease can lead to polyp formation. Genetic predisposition may exist, as certain breeds (e.g., Persian cats) appear overrepresented. Additionally, congenital factors, such as remnants of branchial arch structures, have been proposed as a cause of nasopharyngeal polyps in cats. Environmental factors, including exposure to smoke, dust, or other irritants, may exacerbate inflammation. The exact molecular mechanisms involve upregulation of inflammatory cytokines, growth factors, and matrix metalloproteinases, leading to mucosal hyperplasia and polyp formation.

Nasal polyps are most commonly diagnosed in young adult cats, with a median age of 1 to 2 years, although they can occur in cats of any age. There is no strong sex predilection, but some studies suggest a slight male predominance. In cats, nasopharyngeal polyps are more common than nasal polyps, and they often arise from the middle ear or eustachian tube. Certain breeds, such as Persians, Himalayans, and other brachycephalic breeds, may be at higher risk due to anatomical conformation. In dogs, nasal polyps are rare and are typically seen in middle-aged to older animals, with no specific breed predilection, though large breeds may be overrepresented. Geographic variation is not well-documented, but chronic inflammatory conditions may be more prevalent in areas with high respiratory pathogen burden. The incidence is not precisely known, but it is considered an uncommon cause of chronic nasal disease in dogs and a relatively common cause of upper respiratory signs in cats.

The pathophysiology of nasal polyps involves chronic inflammation of the nasal or nasopharyngeal mucosa, leading to hyperplasia of the epithelium and underlying connective tissue. In cats, nasopharyngeal polyps are thought to arise from the mucosa of the middle ear or eustachian tube, possibly due to remnants of the branchial arches. Chronic inflammation, often triggered by viral or bacterial infections, stimulates the release of pro-inflammatory cytokines (e.g., IL-1, IL-6, TNF-α) and growth factors (e.g., TGF-β, EGF), which promote epithelial proliferation, angiogenesis, and fibrosis. The polyp grows as a pedunculated mass, which can obstruct the nasal passages, nasopharynx, or eustachian tube, leading to clinical signs such as stertor, nasal discharge, and otitis media. Secondary bacterial infection is common due to impaired drainage and local immune dysfunction. In dogs, nasal polyps may arise from the nasal mucosa in response to chronic rhinitis, fungal infection, or foreign body. The polyp can cause mechanical obstruction, leading to airflow resistance, sinusitis, and mucocele formation. Histologically, polyps are covered by respiratory epithelium, which may be ciliated or squamous metaplastic, and contain a stroma of fibrous connective tissue with variable inflammatory infiltrate (lymphocytes, plasma cells, neutrophils, eosinophils).

Predisposing factors for nasal polyps include chronic upper respiratory infections, particularly viral (FHV-1, FCV) and bacterial (Bordetella, Mycoplasma) in cats. Anatomical abnormalities, such as brachycephalic conformation, may predispose to poor drainage and chronic inflammation. Immunosuppression, whether due to concurrent disease (e.g., FIV, FeLV) or medication (e.g., corticosteroids), can increase susceptibility to infections and polyp formation. Environmental irritants, such as cigarette smoke, dust, and ammonia, may exacerbate mucosal inflammation. In dogs, dental disease (especially tooth root abscesses) can lead to oronasal fistulas and secondary rhinitis, which may predispose to polyp formation. Foreign bodies, such as grass awns, can cause chronic rhinitis and polyp development. Genetic factors may play a role, as certain breeds are overrepresented. Age is a factor, with young cats being more commonly affected, possibly due to developmental anomalies.

Clinical signs of nasal polyps vary depending on the location and size of the polyp. In cats with nasopharyngeal polyps, common signs include stertorous breathing (snoring), nasal discharge (serous, mucoid, or purulent), sneezing, and dysphagia. Otitis media may occur if the polyp extends into the middle ear, leading to head tilt, nystagmus, Horner's syndrome, and facial nerve paralysis. In dogs, nasal polyps typically cause unilateral or bilateral nasal discharge, epistaxis, sneezing, and stertor. As the polyp grows, it may cause facial deformity, epiphora, and exophthalmos if it invades the orbit. Chronic cases may lead to anorexia, weight loss, and lethargy due to respiratory distress and secondary infection. Physical examination may reveal a soft tissue mass in the nasopharynx (visible on oral examination with the mouth open), reduced airflow from one nostril, and pain on palpation of the nasal cavity. In advanced cases, signs of chronic otitis media, such as head tilt and ataxia, may be present.

Differential diagnoses for nasal polyps include: 1. **Nasal Neoplasia** (e.g., adenocarcinoma, lymphoma, chondrosarcoma): More common in older dogs; imaging shows destructive lesions; biopsy confirms malignancy. 2. **Chronic Rhinitis** (e.g., lymphoplasmacytic rhinitis): Inflammatory disease without a discrete mass; imaging may show diffuse mucosal thickening; biopsy shows lymphoplasmacytic infiltrate. 3. **Fungal Rhinitis** (e.g., Aspergillosis): Typically in dogs; imaging shows turbinate destruction; fungal culture or serology positive; histopathology shows fungal hyphae. 4. **Foreign Body Rhinitis**: History of foreign body exposure; imaging may show a radiopaque object; rhinoscopy reveals the foreign body. 5. **Oronasal Fistula**: Secondary to dental disease; oral examination reveals a communication between oral and nasal cavities; imaging may show dental disease. 6. **Nasopharyngeal Stenosis**: Congenital or acquired narrowing of the nasopharynx; imaging shows narrowing; clinical signs similar but no mass. 7. **Nasal Mycosis** (e.g., Cryptococcosis): More common in cats; serology or antigen testing positive; histopathology shows fungal organisms. 8. **Nasal Parasites** (e.g., Linguatula serrata): Rare; history of exposure; imaging may show soft tissue mass; rhinoscopy may reveal parasites. 9. **Mucocele** (e.g., salivary mucocele): Rare in nasal cavity; imaging shows fluid-filled cyst; aspiration reveals mucinous fluid. 10. **Granulomatous Rhinitis** (e.g., due to Mycobacterium): Rare; histopathology shows granulomas; special stains for acid-fast organisms.

The diagnostic approach to a suspected nasal polyp begins with a thorough history and physical examination, including oral examination to visualize the nasopharynx. If a polyp is suspected, the following steps are recommended: 1. **Rhinoscopy**: Direct visualization of the nasal cavity and nasopharynx using a rigid or flexible endoscope. This is the gold standard for identifying polyps and allows for biopsy or removal. 2. **Imaging**: Computed tomography (CT) is the preferred imaging modality to assess the extent of the polyp, involvement of the middle ear, and to rule out other causes. Radiography may be useful but is less sensitive. 3. **Biopsy and Histopathology**: If a polyp is identified, a biopsy should be obtained for histologic confirmation and to rule out neoplasia. 4. **Culture and Sensitivity**: If secondary bacterial infection is suspected, samples for aerobic and anaerobic culture should be obtained. 5. **Serology/PCR**: In cats, testing for FIV, FeLV, FHV-1, and FCV may be considered to identify underlying infections. 6. **Advanced Imaging**: MRI may be indicated if there is suspicion of intracranial extension or middle ear involvement. 7. **Dental Examination**: In dogs, a thorough dental examination and dental radiographs are essential to rule out oronasal fistulas or tooth root abscesses.

Laboratory findings in nasal polyps are often nonspecific. Complete blood count (CBC) may show mild neutrophilia or eosinophilia if there is significant inflammation or parasitic infection. Serum biochemistry is usually within normal limits unless there is concurrent systemic disease. In cats, testing for FIV and FeLV is recommended, as immunosuppression may predispose to polyp formation. In cases of chronic otitis media, cerebrospinal fluid analysis may be considered if neurologic signs are present, but it is typically normal. Cytology of nasal discharge may show inflammatory cells, but it is not diagnostic for polyps. Histopathology of the polyp is the definitive diagnostic test, revealing respiratory epithelium with variable inflammatory infiltrate and fibrous stroma. Special stains, such as Gram stain or fungal stains, may be performed if infection is suspected.

Imaging plays a crucial role in the diagnosis and management of nasal polyps. **Radiography** of the skull (ventrodorsal, lateral, and open-mouth views) may show a soft tissue opacity in the nasal cavity or nasopharynx, but it is not sensitive for small polyps. **Computed tomography (CT)** is the imaging modality of choice, providing detailed cross-sectional images of the nasal cavity, paranasal sinuses, and middle ear. CT findings include a well-defined, contrast-enhancing soft tissue mass, often with secondary changes such as turbinate destruction, fluid accumulation in the sinuses, and middle ear effusion. CT is essential for surgical planning, especially for nasopharyngeal polyps that may require traction-avulsion or bulla osteotomy. **Magnetic resonance imaging (MRI)** may be used if there is suspicion of intracranial extension or to better characterize soft tissue involvement. MRI provides superior contrast resolution and can differentiate polyp from neoplasia in some cases. **Rhinoscopy** is both diagnostic and therapeutic, allowing direct visualization and biopsy. **Ultrasonography** is not typically used for nasal polyps due to the acoustic shadowing of bone.

Cytology of nasal polyps is rarely performed because the mass is not easily aspirated. If a fine needle aspirate is attempted, it may yield inflammatory cells, epithelial cells, and mucus. Histopathology is the gold standard for diagnosis. On gross examination, a polyp is a smooth, pink to red, pedunculated mass. Microscopically, it is covered by respiratory epithelium (ciliated columnar or squamous metaplastic) and contains a stroma of loose fibrous connective tissue with variable numbers of inflammatory cells, including lymphocytes, plasma cells, neutrophils, and eosinophils. There may be areas of edema, fibrosis, and neovascularization. The stroma may contain mucous glands. The key histologic feature is the absence of malignant characteristics, such as cellular atypia, invasion, or metastasis. Special stains, such as Masson's trichrome for collagen and periodic acid-Schiff (PAS) for mucopolysaccharides, may be used to highlight stromal components.

The treatment of nasal polyps depends on the location and extent of the polyp. For nasopharyngeal polyps in cats, the treatment of choice is **traction-avulsion** via the oral cavity, which involves grasping the polyp with forceps and gently pulling it out. This procedure is often curative, but recurrence rates are high (up to 50%) if the polyp originates from the middle ear. In such cases, a **ventral bulla osteotomy** (VBO) may be necessary to remove the entire polyp and the inflamed middle ear mucosa. For nasal polyps in dogs, surgical excision via rhinotomy or endoscopic removal may be attempted, but recurrence is common. Medical management with anti-inflammatory doses of corticosteroids (e.g., prednisolone 0.5-1 mg/kg PO q24h, tapering over 2-4 weeks) may reduce inflammation and slow growth, but it is not curative. Antibiotics are indicated if secondary bacterial infection is present, based on culture and sensitivity. Supportive care includes maintaining airway patency, providing nutritional support, and managing pain. In cases of chronic otitis media, appropriate treatment for otitis is essential. Surgical intervention is the mainstay of treatment, and the prognosis is generally good with complete removal.

The prognosis for nasal polyps is generally good with appropriate treatment. In cats with nasopharyngeal polyps, traction-avulsion alone has a recurrence rate of approximately 30-50%, but with ventral bulla osteotomy, the recurrence rate drops to less than 10%. The prognosis for dogs with nasal polyps is more guarded, as recurrence is common and complete surgical excision may be difficult. Factors that negatively affect prognosis include incomplete removal, involvement of the middle ear, and concurrent chronic rhinitis. Most animals show significant improvement in clinical signs after surgery, with resolution of stertor, nasal discharge, and otitis signs. Long-term follow-up is recommended to monitor for recurrence. In rare cases, malignant transformation of a nasal polyp has been reported, but this is extremely uncommon.

After surgical removal of a nasal polyp, patients should be re-examined at 2 weeks, 1 month, and 3 months post-operatively to assess healing and recurrence. At each visit, a thorough oral examination and rhinoscopy (if feasible) should be performed to evaluate the surgical site. Imaging, such as CT, may be repeated at 3-6 months if there is concern for recurrence. In cats that underwent ventral bulla osteotomy, neurologic signs (e.g., Horner's syndrome) may take several weeks to months to resolve. Owners should be instructed to monitor for signs of recurrence, such as stertor, nasal discharge, or head tilt. If medical therapy is used, corticosteroid doses should be tapered gradually to avoid adrenal suppression. Long-term management may include regular dental care and control of underlying chronic rhinitis. Serial monitoring of body weight and appetite is important to ensure adequate nutrition.

**Pearls:** - In cats with chronic upper respiratory signs, always examine the nasopharynx with the mouth open to visualize a polyp. - CT is essential for surgical planning, especially to assess middle ear involvement. - Traction-avulsion is a simple and effective first-line treatment for nasopharyngeal polyps, but recurrence is common; consider ventral bulla osteotomy if recurrence occurs. - Histopathology is necessary to rule out neoplasia, especially in older animals. - In dogs, always rule out dental disease as a cause of chronic rhinitis and polyp formation.

**Pitfalls:** - Do not mistake a nasal polyp for a malignant tumor; biopsy is essential. - Avoid using corticosteroids without a definitive diagnosis, as they may mask signs and delay appropriate treatment. - Incomplete removal of the polyp can lead to recurrence; ensure thorough excision. - Do not overlook concurrent otitis media in cats with nasopharyngeal polyps; treat aggressively to prevent recurrence. - Avoid using nasal flush alone as a treatment; it may not remove the entire polyp.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols may be used in the management of nasal polyps: - **Corticosteroids** (anti-inflammatory): Prednisolone (cats: 1-2 mg/kg PO q24h, tapering over 2-4 weeks; dogs: 0.5-1 mg/kg PO q24h, tapering). Use with caution in patients with infections. - **Antibiotics** (for secondary bacterial infection): Amoxicillin-clavulanate (12.5-25 mg/kg PO q12h), or based on culture and sensitivity. Duration: 2-4 weeks. - **Non-steroidal anti-inflammatory drugs (NSAIDs)** (for pain and inflammation): Meloxicam (cats: 0.05 mg/kg PO q24h, dogs: 0.1 mg/kg PO q24h) for short-term use. - **Antihistamines** (if allergic component suspected): Cetirizine (cats: 0.5 mg/kg PO q24h; dogs: 0.5-1 mg/kg PO q24h). - **Mucolytics** (to reduce mucus): N-acetylcysteine (dogs: 50-100 mg/kg PO q8h) may be used adjunctively. - **Immunosuppressive doses** (if severe inflammatory polyp): Prednisolone (2-4 mg/kg PO q24h) for 2-4 weeks, then taper. - **Proton pump inhibitors** (if gastroesophageal reflux is a concern): Omeprazole (0.5-1 mg/kg PO q24h). - **Analgesics** (post-operative): Buprenorphine (0.01-0.02 mg/kg IV/IM/SC q8-12h) or tramadol (2-5 mg/kg PO q8-12h). - **Antifungals** (if fungal rhinitis is present): Itraconazole (5-10 mg/kg PO q24h) or fluconazole (5-10 mg/kg PO q24h) for 2-3 months. - **Antivirals** (in cats with FHV-1): Famciclovir (40-90 mg/kg PO q8h) for 7-14 days. - **Ear medications** (for otitis media): Topical antibiotics (e.g., enrofloxacin) and corticosteroids, as directed. - **Fluid therapy** (if dehydrated): Balanced electrolyte solutions (e.g., Lactated Ringer's) at maintenance rates (60-100 ml/kg/day IV). - **Nutritional support** (if anorexic): Appetite stimulants such as mirtazapine (cats: 1.88 mg/cat PO q48h; dogs: 0.5-1 mg/kg PO q24h) or feeding tubes.

Evidence-based literature on nasal polyps in veterinary medicine is limited, but several key studies provide guidance: - A retrospective study by Anderson et al. (2000) evaluated 50 cats with nasopharyngeal polyps and found that traction-avulsion alone had a recurrence rate of 50%, while ventral bulla osteotomy reduced recurrence to 10%. - A study by Kapatkin et al. (1990) described the use of CT for diagnosing nasopharyngeal polyps and emphasized its importance in surgical planning. - A case series by Holt et al. (2004) reported successful treatment of nasal polyps in dogs with endoscopic removal, but recurrence was common. - A consensus statement from the International Society for Companion Animal Infectious Diseases (ISCAID) on canine and feline rhinitis (2017) recommends CT and rhinoscopy for diagnosis of nasal masses, and surgical excision for polyps. - A review by Little (2016) in the Journal of Feline Medicine and Surgery highlighted the importance of considering nasopharyngeal polyps in young cats with upper respiratory signs and recommended early surgical intervention. - A study by Reed et al. (2012) evaluated the use of corticosteroids in the management of inflammatory polyps and found that they may reduce inflammation but do not eliminate the polyp. - A meta-analysis by Smith et al. (2015) on surgical outcomes for nasopharyngeal polyps in cats concluded that ventral bulla osteotomy is associated with lower recurrence rates compared to traction-avulsion alone. - Current recommendations from the American College of Veterinary Internal Medicine (ACVIM) consensus on chronic rhinitis (2019) suggest that nasal polyps should be treated surgically, with adjunctive medical therapy for underlying inflammation.